Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study-Reference-Cited by-同舟云学术

Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study

Published:2018-09-26 Issue:12 Volume:7 Page:e1502905
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Pedersen Magnus¹²,Westergaard Marie Christine Wulff¹,Milne Katy³,Nielsen Morten¹²^ORCID,Borch Troels Holz¹²^ORCID,Poulsen Lars Grønlund⁴,Hendel Helle Westergren⁵,Kennedy Mia³,Briggs Gillian³,Ledoux Stacey³,Nøttrup Trine Jakobi⁶,Andersen Pernille⁷,Hasselager Thomas⁸,Met Özcan¹²^ORCID,Nelson Brad H.³⁹,Donia Marco¹²,Svane Inge Marie¹²

Affiliation:

1. Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark

2. Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark

3. Deeley Research Centre, BC Cancer, Victoria, Canada

4. Department of Gynecology and Obstetrics, Herlev Hospital, University of Copenhagen, Herlev, Denmark

5. Department of Clinical Physiology and Nuclear Medicine, Herlev Hospital, University of Copenhagen, Herlev, Denmark

6. Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

7. Department of Clinical Immunology and Stem Cell Facility, Herlev Hospital, University of Copenhagen, Herlev, Denmark

8. Department of Pathology, Herlev Hospital, University of Copenhagen, Herlev, Denmark

9. Department of Medical Genetics, University of British Columbia, Vancouver, Canada

Funder

Herlev Research Council

The Danish Cancer Society

Ovacure

The Anticancer Fund

The Aase and Einar Danielsen Foundation

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1502905

Reference39 articles.

1. Global cancer statistics, 2012

2. Trends in the overall survival of cancer patients diagnosed 1964–2003 in the Nordic countries followed up to the end of 2006: The importance of case-mix

3. Ovarian cancer: a focus on management of recurrent disease

4. Latest research and treatment of advanced-stage epithelial ovarian cancer

5. Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach;Nature Reviews Clinical Oncology;2024-09-04

2. Engineered T cells for Colorectal Cancer;Immunotherapy;2024-09-04

3. T cell exhaustion and senescence for ovarian cancer immunotherapy;Seminars in Cancer Biology;2024-09

4. Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL products;OncoImmunology;2024-08-22

5. Adoptive T cell therapy for ovarian cancer;Gynecologic Oncology;2024-07